Viemed Healthcare (VMD) Free Cash Flow Growth (3y) (2021 - 2026)
Viemed Healthcare (VMD) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -0.27% |
| 10 | Viemed Healthcare | 466.14 Mn | 456.38 Mn | 42.83 Mn | -38.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.40% |
| Dec 31, 2025 | 48.52% |
| Sep 30, 2025 | 25.50% |
| Jun 30, 2025 | -9.17% |
| Mar 31, 2025 | -28.25% |
| Dec 31, 2024 | 66.47% |
| Sep 30, 2024 | -63.42% |
| Jun 30, 2024 | 18.24% |
| Mar 31, 2024 | -34.67% |
| Dec 31, 2023 | 31.00% |
| Sep 30, 2023 | -33.44% |
| Jun 30, 2023 | -21.05% |
| Mar 31, 2023 | 53.40% |
| Dec 31, 2022 | -26.69% |
| Sep 30, 2022 | 80.43% |
| Jun 30, 2022 | -45.73% |
| Mar 31, 2022 | 136.30% |
| Dec 31, 2021 | 15.17% |
| Sep 30, 2021 | 6.73% |